StockData
Petros Pharmaceuticals, Inc. logo

Petros Pharmaceuticals, Inc. (PTPI) stock

PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$0.00+0.00 (+5.56%)

Close on Oct 19, 2026Market cap $135.07KP/E –Yield –

Petros Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Petros Pharmaceuticals's pe ratio was 0.0× on Jul 31, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 20260.0×–

More Petros Pharmaceuticals figures

See a number that looks wrong?